# Nephron Sc Inc – FDA Inspection, Apr 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/e0bb56c2-42c7-4743-87be-10c0249c6d04
Source feed: FDA_Inspections

> FDA inspection 1015133 of Nephron Sc Inc, April 21, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015133
- Company Name: Nephron Sc Inc
- Inspection Date: 2017-04-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1274364 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/cbad2da2-21ae-41c8-8520-a2c9826226d4)
- [FDA Inspection 1247772 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/8d6892d9-27b4-4159-a498-fc8bfe4ed24c)
- [FDA Inspection 1229051 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/7610bef4-1d7f-4cb3-bd8f-ee549586e73d)
- [FDA Inspection 1197994 - 2023-02-10](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/5c6a8c2a-0cd7-4f46-bc21-9f3d518ae97d)
- [FDA Inspection 1168119 - 2022-04-20](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/dbba7c32-d2ce-4576-b4c6-077bb9144c98)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/bonita-s-chester/cc6ce6f4-bb5c-452a-820c-3339361bc8b2)
- [FDA Associated Person](https://www.keypedia.com/people/diane-p-goyette/e1f55d42-cb53-4872-aae0-44a442a0022b)
- Issuing Officer

Company: https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c